• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Greece Shuts the Door on Cannabis Flower in Retail

ATHENS – Greece's medicines regulator has ordered an immediate, nationwide halt to the retail sale of dried Cannabis flower, pulling a product that had built a foothold in c-stores, vending machines, and specialized shops across ...

Glass House Brands Triggers Warrant Acceleration

LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...

Vireo Growth Completes $81 Million Equity Offering

LOS ANGELES- Vireo Growth Inc., a Minneapolis-based cannabis multistate operator, has successfully concluded an oversubscribed private placement, raising approximately $81 million. Initially targeting $75 million, the company issued 129,536,874 subordinate voting shares at $0.625 per ...

Colorado Considers Psilocybin Prescription Legislation

LOS ANGELES- Colorado lawmakers have introduced House Bill 25-1063, a bipartisan proposal that would permit the prescription of crystalline polymorph psilocybin—a synthetic form of the psychedelic compound—contingent upon approval by the U.S. Food and Drug ...

High Tide Acquires Majority Stake in German Cannabis Firm

LOS ANGELES- High Tide Inc., a Canadian cannabis enterprise, has acquired a 51% stake in Frankfurt-based pharmaceutical company Purecan for approximately €4.8 million. This strategic move marks High Tide's entry into Germany's medical cannabis market. ...

DEA Judge Cancels Cannabis Rescheduling Hearings

LOS ANGELES- The Drug Enforcement Administration (DEA) has canceled its upcoming hearings on the proposed rescheduling of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney issued the cancellation following legal challenges ...

  • CanPay

Worried About IRS Audits? What You Need to Know

LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market ...

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

Subscribe To Our Newsletter

Go to Top